• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC DECANAV; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC DECANAV; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING Back to Search Results
Catalog Number R7F282CT
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 12/13/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Tamponade was observed at the end of the case, after the catheter was pulled out from the patient.Action taken when the event occurred was "drain".Additional information was received indicating the event used during use of the bwi products during mapping and ablation phase but observed the tamponade only at the end of the case.The physician¿s opinion on the cause of the adverse event were bwi product malfunction and patient condition.There was no evidence of steam pop.No surgery was required.Patient was reported to have fully recovered.On 6-feb-2025, additional information was received indicating there were no bwi product malfunctions and ablation was not done prior to the adverse event.Device evaluation details: the product was returned to johnson & johnson medtech (j&j medtech) for evaluation.A visual inspection and revision of all features were performed following j&j medtech procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of johnson & johnson medtech¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.# (b)(4).
 
Event or Problem Description
It was reported that a patient underwent an idiopathic ventricular tachycardia ablation procedure with a decanav and the patient experienced cardiac tamponade that required "drain".Tamponade was observed at the end of the case, after the catheter was pulled out from the patient.Action taken when the event occurred was "drain".Additional information was received indicating the event used during use of the bwi products during mapping and ablation phase but observed the tamponade only at the end of the case.The physician¿s opinion on the cause of the adverse event were bwi product malfunction and patient condition.There was no evidence of steam pop.No surgery was required.Patient was reported to have fully recovered.
 
Additional Manufacturer Narrative
On 27-jan-20245, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DECANAV
Common Device Name
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key21127888
Report Number2029046-2025-00112
Device Sequence Number7677486
Product Code DRF
UDI-Device Identifier10846835008807
UDI-Public(01)10846835008807(17)251017(10)31475723M
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K080425
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/17/2025
Device Catalogue NumberR7F282CT
Device Lot Number31475723M
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/13/2024
Supplement Date Received by Manufacturer01/27/2025
01/30/2025
Initial Report FDA Received Date01/10/2025
Supplement Report FDA Received Date01/28/2025
02/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/18/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
7FR DECAN,11P, F, 2.4MMLE, 282MM.; NGEN RF GENERATOR.
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient SexMale
-
-